Literature DB >> 9359977

Major depression and cardiac autonomic control.

M Lehofer1, M Moser, R Hoehn-Saric, D McLeod, P Liebmann, B Drnovsek, S Egner, G Hildebrandt, H G Zapotoczky.   

Abstract

We investigated autonomic control of heart rate in patients with major depression, melancholic type. Twenty-three depressed inpatients who were being treated with tricyclic antidepressants and 23 depressed patients who were taking no medications were compared with age- and sex-matched control groups on resting cardiac vagal tone and heart rate. In unmedicated depressed patients, cardiac vagal tone was comparable to that of control subjects, but heart rate was significantly higher. This increase in heart rate may have been due to sympathetic activation caused by anxiety, since the depressed patients were significantly more anxious than the control subjects. Medicated patients exhibited diminished cardiac vagal tone and higher heart rate than unmedicated patients and controls. This was probably due to the anticholinergic effects of the antidepressants. Our findings suggest that cardiac vagal tone is not lower than normal in patients with depression, melancholic type.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9359977     DOI: 10.1016/S0006-3223(96)00494-5

Source DB:  PubMed          Journal:  Biol Psychiatry        ISSN: 0006-3223            Impact factor:   13.382


  22 in total

1.  The impact of depression on social economic decision making.

Authors:  Katia M Harlé; John J B Allen; Alan G Sanfey
Journal:  J Abnorm Psychol       Date:  2010-05

2.  Autonomic cardiac control in depressed adolescents.

Authors:  Michelle L Byrne; Lisa Sheeber; Julian G Simmons; Betsy Davis; Joann Wu Shortt; Lynn Fainsilber Katz; Nicholas B Allen
Journal:  Depress Anxiety       Date:  2010-06-23       Impact factor: 6.505

3.  Cardiac vagal control in nonmedicated depressed women and nondepressed controls: impact of depression status, lifetime trauma history, and respiratory factors.

Authors:  Jill M Cyranowski; Tara L Hofkens; Holly A Swartz; Kristen Salomon; Peter J Gianaros
Journal:  Psychosom Med       Date:  2011-03-01       Impact factor: 4.312

4.  Combinations of resting RSA and RSA reactivity impact maladaptive mood repair and depression symptoms.

Authors:  Ilya Yaroslavsky; Lauren M Bylsma; Jonathan Rottenberg; Maria Kovacs
Journal:  Biol Psychol       Date:  2013-07-01       Impact factor: 3.251

5.  Atypical patterns of respiratory sinus arrhythmia index an endophenotype for depression.

Authors:  Ilya Yaroslavsky; Jonathan Rottenberg; Maria Kovacs
Journal:  Dev Psychopathol       Date:  2014-11

6.  Heart rate variability assessment in Japanese workers recovered from depressive disorders resulting from job stress: measurements in the workplace.

Authors:  Mikio Takada; Takeshi Ebara; Michihiro Kamijima
Journal:  Int Arch Occup Environ Health       Date:  2009-12-12       Impact factor: 3.015

7.  Rumination and Cognitive Distraction in Major Depressive Disorder: An Examination of Respiratory Sinus Arrhythmia.

Authors:  Joelle LeMoult; K Lira Yoon; Jutta Joormann
Journal:  J Psychopathol Behav Assess       Date:  2015-08-23

8.  Heart rate variability (HRV) in adolescent females with anxiety disorders and major depressive disorder.

Authors:  E Henje Blom; E M Olsson; E Serlachius; M Ericson; M Ingvar
Journal:  Acta Paediatr       Date:  2010-01-28       Impact factor: 2.299

9.  Respiratory sinus arrhythmia reactivity in current and remitted major depressive disorder.

Authors:  Lauren M Bylsma; Kristen Salomon; April Taylor-Clift; Bethany H Morris; Jonathan Rottenberg
Journal:  Psychosom Med       Date:  2013-12-23       Impact factor: 4.312

10.  Juvenile onset depression alters cardiac autonomic balance in response to psychological and physical challenges.

Authors:  Lauren M Bylsma; Ilya Yaroslavsky; Jonathan Rottenberg; J Richard Jennings; Charles J George; Enikő Kiss; Krisztina Kapornai; Kitti Halas; Roberta Dochnal; Eszter Lefkovics; István Benák; Ildikó Baji; Ágnes Vetró; Maria Kovacs
Journal:  Biol Psychol       Date:  2015-07-29       Impact factor: 3.251

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.